RAPP - CIK 0002012593
Rapport Therapeutics, Inc. trades as RAPP and has a market capitalization of $1.87 B, making it the #2142 largest US-listed company by market value. This page tracks Rapport Therapeutics, Inc. through 197 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-27 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Insider trade | 4 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 |
The largest companies sharing Rapport Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
Rapport Therapeutics, Inc. (RAPP) has a market capitalization of $1.87 B as of 2026-05-29, ranking #2142 among US-listed companies.
In its latest fiscal year Rapport Therapeutics, Inc. reported a net loss of $111.48M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.